Consistently, we found that TRIM21 protein levels were frequently downregulated in colorectal and breast cancers by IHC staining analysis of TRIM21 expression in multiple cohorts of colorectal and breast cancers using tissue microarrays (TMAs; obtained from US Biomax) (Figure 6, A and B). The gene discussed is TRIM21; the disease is breast carcinoma.